AusCann Group Holdings Ltd $0.040
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:08am | ||||
AUSCANN GROUP HOLDINGS LTD
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $18,062,432 (1,390th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 0 |
Shortsold (21-Feb) 50,867 (0.01%) (619th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.06 |
Appendix 4D and Half-Year Financial Report 31 December 2021
AC8 released this announcement to the ASX on 28 February 2022, 17:24. The announcement is marked as price sensitive, and is 30 page(s) in length and 759.45kb in size.
You can view all announcements from AC8 and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AC8 | |
|---|---|
| Final Director's Interest Notice - C. Mews | 29 June 2023, 9:44 |
| Initial Director's Interest Notice - B. Mitchell | 29 June 2023, 9:44 |
| Appointment of Independent Non-Executive Director | 29 June 2023, 9:19 |
| Appendix 4D and Half-Year Financial Report 31 December 2021 | 28 February 2022, 17:24 |
| Notification regarding unquoted securities - AC8 | 17 February 2022, 9:15 |
| AusCann Receives Positive MOC from the U.S. FDA for CPAT-01 | 8 February 2022, 10:59 |
| December 2021 Quarterly Activities and Cashflow Reports | 28 January 2022, 8:56 |
If you were already registered, log in here.
If you were already registered, log in here.